Dear editor,
Stroke associated with drug abuse has been reported frequently; illicit drug use has been casually implicated in 6% of all stroke in some hospital series and in 15% to 40% of stroke in young patients. 1 The most commonly implicated drugs include cocaine, heroin, and amphetamines. Recently, there have been few case reports of stroke associated with synthetic cannabis and with the rising use of synthetic cannabis, it is very important to understand this. At this stage, there is an enormous interest in research aiming to understand the mechanism, improve diagnosis, and manage the synthetic cannabis associated stroke and associated morbidity, not only for addiction psychiatrists but also for stroke neurologists.
Synthetic cannabis represents a relatively new class of designer drugs that have recently emerged as popular alternative to marijuana. These drugs are mostly smoked for their THC-like effects. In spite of the risks, the synthetic cannabis is immensely popular among teens. A 2014 survey conducted by the National Institute on Drug Abuse found that second to only real marijuana, it was the most used illicit drug among high school seniors with 5.8% reported use.
In our recent review, we have systematically identified stroke associated with synthetic cannabis userelated publications from PubMed, covering the period from 2013 to 2015. We identified six reported cases of acute ischemic stroke with synthetic cannabis use. [2] [3] [4] All these patients had positive drug use history for synthetic cannabis use, negative urine drug screen, and negative tests for genetic factors that might put these patients at the risk of stroke makes synthetic cannabis the most possible cause of their stroke. However, lack of sensitive and specific test confirming synthetic cannabis as a cause of stroke was a limiting factor in these case reports.
The mechanism by which synthetic cannabis causes stroke in people is still unknown due to lack of the information about the exact chemical composition and toxicology of synthetic cannabis. Considering the fact about the increased potency of synthetic cannabis, proposed mechanisms of stroke relating to cannabis use such as altered cerebral autoregulation, cerebral vasospasm, vasculopathy, vasculitis, and cardioembolism might be contributing in the development of stroke with synthetic cannabis. 1 In addition to that, cross reactivity with other receptors and multiple active metabolites may strongly promote a prothrombotic state resulting in stroke in presence of other minor risk factors. 4 According to Centers for Disease Control and Prevention, 34% people hospitalized for stroke were younger than 65 years in 2009. Stroke in young population can result in considerable amount of morbidity and mortality in terms of residual weakness, paralysis, and blindness. Increasing popularity of synthetic cannabis among teenagers makes them more vulnerable to stroke risk related to its use. Our preliminary review may suggest that inclusion of specific diagnostic test in stroke work-up to detect these drugs may help to prevent further stroke-related morbidity in this population.
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